Evome Medical Technologies Inc. EVMT.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -389.35% | -7.60% | 10.02% | 21.39% | 70.67% |
| Total Depreciation and Amortization | -44.82% | 132.58% | 36.78% | 82.55% | 110.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 740.99% | 2.44% | -31.30% | -27.39% | -78.37% |
| Change in Net Operating Assets | 367.02% | 550.24% | 202.78% | 48.06% | 0.08% |
| Cash from Operations | 1,129.89% | 9,797.78% | -28.97% | 58.58% | 87.74% |
| Capital Expenditure | 95.51% | 79.52% | 80.63% | 70.60% | -466.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -41.20% | -41.73% | -10.79% | 61.84% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 78.40% |
| Cash from Investing | 98.84% | 25.44% | 26.85% | 37.01% | 50.65% |
| Total Debt Issued | -130.45% | -209.26% | -216.43% | 161.39% | -67.67% |
| Total Debt Repaid | -538.20% | -122.14% | 97.87% | 89.91% | -13.26% |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | -99.24% | -99.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 331.69% |
| Cash from Financing | -88.38% | -86.97% | 24.62% | 616.78% | -158.52% |
| Foreign Exchange rate Adjustments | 341.31% | 78.00% | 549.20% | 324.72% | 1,951.04% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.25% | 31.37% | 31.95% | 78.70% | -29.09% |